Oxybutynin chloride and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Common peroneal nerve dysfunction is reported as a side effect among people who take Oxybutynin chloride (oxybutynin chloride), especially for people who are female, 50-59 old, also take Ampyra, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Oxybutynin chloride. It is created by eHealthMe based on reports of 10,417 people who have side effects when taking Oxybutynin chloride from the FDA, and is updated regularly.

What is Oxybutynin chloride?

Oxybutynin chloride has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 10,830 Oxybutynin chloride users. Check the latest studies of Oxybutynin chloride.

What is Common peroneal nerve dysfunction?

Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 653 drugs and 1,129 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.

On Apr, 24, 2026

10,417 people reported to have side effects when taking Oxybutynin chloride.
Among them, 38 people (0.36%) have Common peroneal nerve dysfunction.

Could Oxybutynin chloride cause Common peroneal nerve dysfunction?

Among these 38 people:

What is the gender of people who have Common peroneal nerve dysfunction when taking Oxybutynin chloride? *

female: 92.11 %
male: 7.89 %

What is the age of people who have Common peroneal nerve dysfunction when taking Oxybutynin chloride? *

What are other drugs people take besides Oxybutynin chloride? *

What are other side effects people have besides Common peroneal nerve dysfunction? *

Gait Disturbance: 18 people, 47.37%
Fatigue (feeling of tiredness): 13 people, 34.21%
Memory Loss: 11 people, 28.95%
Balance Disorder: 10 people, 26.32%
Weakness: 9 people, 23.68%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 21.05%
Weight Decreased: 7 people, 18.42%
Pain: 7 people, 18.42%
Cancer - Throat Or Larynx: 7 people, 18.42%
Ingrowing Nail: 7 people, 18.42%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 23 people, 60.53%
Gait Disturbance: 15 people, 39.47%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 15.79%
Pain: 4 people, 10.53%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 2.63%
Bladder Disorder: 1 person, 2.63%
Chickenpox (infection with varicella zoster virus): 1 person, 2.63%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 2.63%
Depression: 1 person, 2.63%
Diabetes: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin chloride and have Common peroneal nerve dysfunction?

- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxybutynin chloride:

Oxybutynin chloride (10,830 reports)

Browse all side effects of Oxybutynin chloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (653 drugs)

Browse all the conditions that are associated with Common peroneal nerve dysfunction:

Common peroneal nerve dysfunction (1,129 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Oxybutynin chloride) and Oxybutynin chloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.